Juniper Pharmaceuticals Inc logo

JNP - Juniper Pharmaceuticals Inc News Story

$11.5 0.0  0.0%

Last Trade - 13/08/18

Sector
Healthcare
Size
Micro Cap
Market Cap £n/a
Enterprise Value £n/a
Revenue £39.5m
Position in Universe th / 6846

BRIEF-Juniper Pharmaceuticals Qtrly Basic EPS $0.11

Thu 8th March, 2018 1:08pm
March 8 (Reuters) - Juniper Pharmaceuticals Inc  JNP.O :
    * JUNIPER PHARMACEUTICALS REPORTS FULL-YEAR 2017 FINANCIAL
AND
OPERATING RESULTS
    * JUNIPER PHARMACEUTICALS INC - QTRLY BASIC EARNINGS PER
SHARE
$0.11
    * JUNIPER PHARMACEUTICALS INC - QTRLY REVENUE $11.8 MILLION
VERSUS
$20.9 MILLION
    * JUNIPER PHARMACEUTICALS INC - CASH AND CASH EQUIVALENTS
WERE
$21.4 MILLION AS OF DECEMBER 31, 2017
    * JUNIPER PHARMACEUTICALS - BELIEVES CURRENT CASH AND CASH
EQUIVALENTS, CASH FROM OPERATIONS, WILL BE SUFFICIENT FOR AT
LEAST NEXT TWELVE MONTHS

Source text for Eikon:  ID:nPn1qGPXda 
Further company coverage:  JNP.O 

 ((Bangalore.newsroom@thomsonreuters.com;))
© Stockopedia 2021, Refinitiv, Share Data Services.
This site cannot substitute for professional investment advice or independent factual verification. To use it, you must accept our Terms of Use, Privacy and Disclaimer policies.